http://www.globalresearch.ca/index.php?context=viewArticle&code=%20EN2005103 0&articleId=1169
IS AVIAN FLU ANOTHER PENTAGON HOAX? by F. William Engdahl October 30, 2005 ... 'Rummy Flu' Tamiflu was developed and patented in 1996 by a California biotech firm, Gilead Sciences Inc. Gilead is a NASDAQ (GILD) listed stock company which prefers to maintain a low profile in the current rush to Tamiflu. That might be because of who is tied to Gilead. In 1997, before he became US Secretary of Defense, Donald H. Rumsfeld was named Chairman of the Board of Gilead Sciences, where he remained until early 2001 when he became Defense Secretary. Rumsfeld had been on the board of Gilead since 1988 according to a January 3 1997 company press release. An as-yet-unconfirmed report is that Rumsfeld while Secretary of Defense also purchased an additional stock in his former company, Gilead Sciences Inc., worth $18 million, making him one of its largest if not the largest stock owners today. The Secretary of Defense, the man who allegedly supported the use of contrived intelligence to justify the war on Iraq, is now poised to reap huge gains for a flu panic his Administration has done everything it can to promote. It would be useful to know whether the Pentagon's successor to Douglas Feith's Office of Special Plans developed the strategy of biowarfare behind the current Avian Flu panic. Perhaps some enterprising Congressional committee might look into the entire subject of plausible conflicts of interest regarding Secretary Rumsfeld. Rumsfeld stands to make a fortune on royalties as a panicked world population scrambles to buy a drug worthless in curing effects of alleged Avian Flu. The model suggests the parallel to the brazen corruption of Halliburton Corporation whose former CEO is Vice President Dick Cheney. Cheney's company has so far gotten billions worth of US construction contracts in Iraq and elsewhere. Coincidence that Cheney's closest political friend is Defense Secretary and Avian Flu beneficiary Don Rumsfeld? It is another example of what someone has called the principle of modern US corrupt special interest politics: 'Concentrate the benefits; diffuse the costs' President Bush has ordered the US Government to buy $2 billion worth of Gilead Science's Tamilflu. GMO Chickens come home to roost But Tamiflu conflicts are perhaps just the tip of the iceberg of the Avian Flu story. There is high-level biological research underway in Britain and presumably also the United States to develop a genetic engineering method to make chickens and other birds 'resistant' to Avian Flu viruses. British scientists are reportedly genetically engineering chickens to produce birds resistant to the lethal strains of the H5N1 virus devastating poultry in the Far East. Laurence Tiley, Professor of Microular Virology at Cambridge University and Helen Sang of the Roslin Institute in Scotland are involved in developing 'transgenic chickens' which would have small pieces of genetic material inserted into chicken eggs to allegedly make the chickens H5N1 resistant. Tiley told the Times of London on October 29, 'Once we have regulatory approval, we believe it will only take between four and five years to breed enough chickens to replace the entire world (chicken) population.' The real question in this dubious undertaking is which GMO giants are underwriting the research and development of GMO chickens and who will control their products. It is increasingly clear that the entire saga of Avian Flu is one whose dimensions are only slowly coming to light. What we can see so far is not at all pretty. ------- Global Research Contributing EditorWilliam Engdahl is author of 'A Century of War: Anglo-American Oil Politics and the New World Order, Pluto Press and the soon-to-be released book, 'Seeds of Destruction: The Geopolitics of Gene-ocide'. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ SpamWall: Mail to this addy is deleted unread unless it contains the keyword "igve". _______________________________________________ Futurework mailing list [email protected] http://fes.uwaterloo.ca/mailman/listinfo/futurework
